Copyright
©The Author(s) 2021.
World J Hepatol. Nov 27, 2021; 13(11): 1766-1776
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1766
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1766
Characteristics | Total, N | Peripartum primary liver cancer | P value | |
No, n = 160 | Yes, n = 40 | |||
n (%) / mean ± SD | n (%) / mean ± SD | |||
Age | 0.788 | |||
< 30 | 88 | 69 (43.1) | 19 (47.5) | |
30-34 | 64 | 53 (33.1) | 11 (27.5) | |
35-49 | 48 | 38 (23.8) | 10 (25) | |
mean ± SD1 | 31.3 ± 5.1 | 30.9 ± 4.8 | 0.673 | |
Baseline comorbidity | ||||
HBV | 58 | 47 (29.4) | 11 (27.5) | 0.815 |
Unspecified chronic hepatitis | 2 | 1 (0.6) | 1 (2.5) | 0.286 |
Alcoholic liver disease | 6 | 5 (3.1) | 1 (2.5) | 0.836 |
Cirrhosis | 9 | 6 (3.8) | 3 (7.5) | 0.306 |
Biliary stone | 6 | 4 (2.5) | 2 (5) | 0.407 |
Cholecystitis | 12 | 8 (5) | 4 (10) | 0.234 |
Cholangitis | 10 | 7 (4.4) | 3 (7.5) | 0.417 |
- Citation: Tseng GW, Lin MC, Lai SW, Peng CY, Chuang PH, Su WP, Kao JT, Lai HC. Do peripartum and postmenopausal women with primary liver cancer have a worse prognosis? A nationwide cohort in Taiwan. World J Hepatol 2021; 13(11): 1766-1776
- URL: https://www.wjgnet.com/1948-5182/full/v13/i11/1766.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i11.1766